E-Waste Systems (EWSI) Announces It Has Signed A Letter Of Intent For Its Lead Acquisition In Southeast USA Martin Nielson, CEO of EWSI states, "We are very pleased to have signed the letter of intent for this acquisition. The services, location, customer base, qualifications and team that make up this target will provide us with a solid entry into this important region." The target is significantly profitable and EWSI expects that they have the ability to sustain their growth as a key part of EWSI's plans to establish itself as an important player in this 55B dollar industry. Upon completion, this acquisition would provide complementary services, important geographic location and a customer base which closely matches EWSI's strategic emphasis on servicing OEM's, major retailers, large corporations, and government institutions. Operating from 25,000 sf of modern space, the target delivers an array of end of life services with solid pending credentials, including R2 and ISO. This LOI requires that the names of the company and the terms of the deal be kept confidential to protect customers, suppliers, and employees, but will be announced as soon as the definitive agreement has been executed. Due diligence has commenced and definitive agreements have been tendered. Closing is contingent upon, among other things, completion of two years of PCAOB qualified audits, which are being commissioned. Management plans no immediate changes in the operations or workforces for the target company and expects it will be business as usual in the meantime.
Closing is planned during this year
LONDON, June 14, 2012 /PRNewswire via COMTEX/ -- E-Waste Systems, (OTCBB: EWSI), is pleased to announce today that it has signed a non-binding letter of intent (LOI) to acquire an end of life electronics company in the Southeast USA, as part of its strategy to become a leading provider of e-waste services around the globe.
E-Waste Systems (EWSI) Announces It Has Signed A Letter Of
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Hims & Hers Health Faces Revenue Challenges and Legal Issues
Hims & Hers Revenue Challenges Amid Stock Decline In recent trading sessions, Hims & Hers Health reported notable stock fluctuations as the company unveiled a decline in revenue per customer linked to its customization of GLP-1 medications for weight loss. This announcement caused an almost 11% drop in the stock price. Impacts of Collaboration Termination This steep...
Continue Reading
Entrée Resources Reports Solid Results for Q3 2025
Entrée Resources Ltd. Overview Entrée Resources Ltd. (TSX: ETG; OTCQB: ERLFF), a reputable Canadian mining company focused on the Oyu Tolgoi project, has announced its interim financial results for the third quarter of 2025. This announcement sheds light on its ongoing operations and future plans, emphasizing the company's significant role in one of the world's largest...
Continue Reading
Bucket List Wine Dinners Beckon to Los Angeles
Sipping on the Extraordinary: LA Wine Soiree When was the last time you had a glass of wine that truly feels like you've unlocked a treasure chest? That's what LearnAboutWine.com is going for with their bucket list wine dinners in Los Angeles. Imagine tasting some of the world's most coveted bottles, all served with a level of polish that screams high-end dining. Led by...
Continue Reading
BioLife Solutions Enhances Growth Potential with $73 Million Sale
BioLife Solutions Announces $73 Million Sale of SciSafe In a significant move aimed at reinforcing its strategic direction, BioLife Solutions, Inc. (NASDAQ: BLFS), a prominent player in the development and supply of cell processing tools and services for the cell and gene therapy market, has announced the sale of its biostorage subsidiary, SciSafe Holdings, Inc. The...
Continue Reading
Advancements in Universal Vaccine Development by Dx&Vx
Innovative Pathway Towards a Universal COVID-19 Vaccine In the wake of a global resurgence of COVID-19, Dx&Vx (DXVX) is stepping up its efforts to develop a universal vaccine aimed at providing protection against all variants of the virus. With the recent acquisition of cutting-edge technology, this next-generation vaccine is set to attract significant global interest....
Continue Reading